RV6.F Charles River Laboratories International Inc

Healthcare Biotechnology Frankfurt Exchange
307.20 EUR
Close of Nov 12, 2026
127.95 334.60
Market cap
EUR 14.7B
P/E
388.9x
P/B
5.15x
ROE
13.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is RV6.F undervalued?

Graham number

The Graham number of Charles River Laboratories International Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Charles River Laboratories International Inc fundamental analysis

No fundamental analysis for Charles River Laboratories International Inc yet.

Charles River Laboratories International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical dru…

Full company profile